MRCF has kickstarted a fifth fund to make early-stage investments in medical technologies from its network of member research institutions in Australia and New Zealand.
Medical Research Commercialisation Fund (MRCF), an Australian government-backed initiative investing in technologies from more than 50 Australia and New Zealand-based research institutions and hospitals, has raised an initial A$210m ($148m) for its fifth fund.
The initial close was backed by all of MRCF’s existing investors – biotechnology producer CSL and pension funds Australian Super, Hesta, Statewide and Hostplus, as well as the Australian government.
Like its predecessors, MRCF5 will be managed by venture capital firm Brandon Capital Partners,…
